Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-03

Clinical Trial Update: Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cetuximab (Erbitux) combined with chemotherapy and radiotherapy for esophageal squamous cell carcinoma has completed testing, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERBITUX (cetuximab)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-02-03